戻る Agendas
EMERGING MARKETS UPDATE: WHAT ON EARTH IS GOING ON WITH REGULATOR CONVERGENCE?
Session Chair(s)
David Verbraska, JD, MBA
Vice President, Worldwide Public Affairs & Policy
Pfizer Inc, United States
Clearly identify successes and challenges in this evolving area. This session would provide a brief background on the various players and then discuss in detail the latest initiatives from various stakeholder perspectives.
Learning Objective : Understand what is happening in the rapidly evolving area of global regulatory harmonization, particularly in the emerging markets. Understand the role of ICH, WHO, public-private partnerships and the bio-pharmaceutical companies, current initiatives and challenges.
Speaker(s)
Emerging Regulatory Convergence in Emerging Markets: Too Little, Too Late
Durhane Wong-Rieger, PHD, MA
Canadian Organization For Rare Disorders, Canada
President and Chief Executive Officer
Successes and Challenges of Regulatory Convergence: WHO’s viewpoint
Lembit Rago, DrMed, MD, PHD
Council for International Organizations of Medical Sciences (CIOMS), Switzerland
Secretary General